Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Alpha cell
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Function== Alpha cells function in the maintenance of blood glucose levels. Alpha cells are stimulated to produce glucagon in response to hypoglycemia, epinephrine, amino acids, other hormones, and neurotransmitters.<ref name=":3">{{Cite journal |last1=Yu |first1=Qian |last2=Shuai |first2=Hongyan |last3=Ahooghalandari |first3=Parvin |last4=Gylfe |first4=Erik |last5=Tengholm |first5=Anders |date=July 2019 |title=Glucose controls glucagon secretion by directly modulating cAMP in alpha cells |journal=Diabetologia |language=en |volume=62 |issue=7 |pages=1212–1224 |doi=10.1007/s00125-019-4857-6 |issn=0012-186X |pmc=6560012 |pmid=30953108}}</ref> === Glucagon Secretion and Control of Gluconeogenesis === Glucagon functions to signal the liver to begin [[gluconeogenesis]] which increases glucose levels in the blood.<ref name=":3" /> Glucagon will bind to the glucagon receptors on the plasma membranes of [[hepatocyte]]s (liver cells). This ligand binding causes the activation of [[Adenylyl cyclase|adenylate cyclase]], which causes the creation of [[Cyclic adenosine monophosphate|cyclic AMP]] (cAMP).<ref name=":4">{{Cite journal |last1=Janah |first1=Lina |last2=Kjeldsen |first2=Sasha |last3=Galsgaard |first3=Katrine D. |last4=Winther-Sørensen |first4=Marie |last5=Stojanovska |first5=Elena |last6=Pedersen |first6=Jens |last7=Knop |first7=Filip K. |last8=Holst |first8=Jens J. |last9=Wewer Albrechtsen |first9=Nicolai J. |date=January 2019 |title=Glucagon Receptor Signaling and Glucagon Resistance |journal=International Journal of Molecular Sciences |language=en |volume=20 |issue=13 |pages=3314 |doi=10.3390/ijms20133314 |issn=1422-0067 |pmc=6651628 |pmid=31284506|doi-access=free }}</ref> As the intracellular concentration of cAMP rises, [[protein kinase A]] (PKA) is activated and phosphorylates the transcription factor [[CREB|cAMP Response Element Binding]] (CREB) protein.<ref name=":4" /> CREB then induces transcription of [[Glucose 6-phosphatase|glucose-6-phosphatase]] and [[phosphoenolpyruvate carboxylase]] (PEPCK). These enzymes increase gluconeogenic activity.<ref name=":4" /> PKA also phosphorylates [[Phosphofructokinase 2|phospho-fructokinase 2]] (PFK2)/fructose 2,6-biphsophatase (FBPase2), inhibiting PFK2 and activating FBPase2.<ref name=":4" /> This inhibition decreases intracellular levels of [[Fructose 2,6-bisphosphate|fructose 2,6-biphosphate]] and increases intracellular levels of [[fructose 6-phosphate]] which decreases glycolytic activity and increases gluconeogenic activity.<ref name=":4" /> PKA also phosphorylates [[pyruvate kinase]] which causes an increase in intracellular levels of fructose 1,6-biphosphate and decreases intracellular levels of pyruvate, further decreasing glycolytic activity.<ref name=":4" /> The most important action of PKA in regulating gluconeogenesis is the phosphorylation of phosphorylase kinase which acts to initiate the [[glycogenolysis]] reaction, which is the conversion of [[glycogen]] to glucose, by converting glycogen to glucose 1-phosphate.<ref name=":4" /> Alpha cells also generate [[Glucagon-like peptide-1]] and may have protective and regenerative effect on [[beta cell]]s. They possibly can [[Transdifferentiation|transdifferentiate]] into beta cells to replace lost beta cells.<ref>{{Cite journal|last1=Stanojevic|first1=Violeta|last2=Habener|first2=Joel F.|date=2015-10-08|title=Evolving Function and Potential of Pancreatic Alpha Cells|journal=Best Practice & Research. Clinical Endocrinology & Metabolism|volume=29|issue=6|pages=859–871|doi=10.1016/j.beem.2015.10.002|issn=1521-690X|pmc=4690008|pmid=26696515}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)